Diasome Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing portal-hepatic targeted therapies for metabolic disease, today announced that results from its OPTI-2 Phase 2b ...

Patients with relapsed multiple myeloma treated with the immunotherapy teclistamab lived significantly longer and remained in remission far longer than those receiving standard therapies, according to ...

President Trump has not signed off on the emerging framework, according to U.S. officials. But it could set the table for ...

The stimulator of interferon genes (STING) pathway is a central mediator of innate immunity, sensing cytosolic DNA and triggering type I interferon ...

Season 3 Episode 4 completely altered Ines’s positioning in the endgame meta, transforming her from a traditional caster into a highly fluid, gunplay-driven skirmisher. By shifting her core offensive ...